A novel AARS mutation in a family with dominant myeloneuropathy
A novel AARS mutation in a family with dominant myeloneuropathy
复制标题
DOI:
10.1212/wnl.0000000000001583
复制
发表时间:
2015-05-19
期刊:
影响因子:
9.9
通讯作者:
Scherer, Steven S.
中科院分区:
文献类型:
--
作者:
Motley, William W.;Griffin, Laurie B.;Scherer, Steven S.
Objective: To determine the genetic cause of neurodegeneration in a family with myeloneuropathy.Methods: We studied 5 siblings in a family with a mild, dominantly inherited neuropathy by clinical examination and electrophysiology. One patient had a sural nerve biopsy. After ruling out common genetic causes of axonal Charcot-Marie-Tooth disease, we sequenced 3 tRNA synthetase genes associated with neuropathy.Results: All affected family members had a mild axonal neuropathy, and 3 of 4 had lower extremity hyperreflexia, evidence of a superimposed myelopathy. A nerve biopsy showed evidence of chronic axonal loss. All affected family members had a heterozygous missense mutation c.304G>C (p.Gly102Arg) in the alanyl-tRNA synthetase (AARS) gene; this allele was not identified in unaffected individuals or control samples. The equivalent change in the yeast ortholog failed to complement a strain of yeast lacking AARS function, suggesting that the mutation is damaging.Conclusion: A novel mutation in AARS causes a mild myeloneuropathy, a novel phenotype for patients with mutations in one of the tRNA synthetase genes.